Learn More
Medchemexpress LLC LR-90 | 245075-84-7 | 99.2% | C₃₅H₃₄Cl₂N₄O₈ | 1 ML

Supplier: Medchemexpress LLC HY7638310MM/1ML
LR-90 is an advanced glycation end product (AGE) inhibitor that has shown to inhibit inflammatory responses in human monocytes. It is also utilized in research concerning diabetic animal models.
- Inhibits AGE formation.
- Reduces inflammatory responses in human monocytes.
- Applicable in research related to diabetic animal models.
- Inhibits RAGE, MCP-1, COX-2, IP-10, and NOX2 mRNA expression in THP-1 cells.
- Blocks THP-1 cell adherence to endothelial cells.
- Has no significant effect on the viability of THP-1 cells at tested concentrations.
- Significantly reduces plasma lipids and modestly affects hyperglycemia in ZDF rats.
- Decreases renal AGE, AGER, and lipid peroxidation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.